Greatview Aseptic Packaging Company Limited (GAPACK) has released an inside-information announcement forecasting a sharp deterioration in its financial performance for the year ended 31 December 2025 (FY2025).
GAPACK expects net profit of approximately RMB48.00 million to RMB58.00 million, representing a year-on-year decline of 82.8%–79.2% from the RMB278.30 million recorded in FY2024. Revenue is projected at about RMB1.86 billion, down 17.3% versus RMB2.25 billion a year earlier.
Management attributes the profit contraction to three factors: 1) a change in accounting treatment for the International Business investment in March 2025 that significantly reduced the related share of profit; 2) the absence of a net fair-value gain on financial assets at fair value through profit or loss, which had benefited the prior year; and 3) a lower gross profit margin in the export segment.
The revenue decline reflects both a reduced total sales volume and lower unit prices for exported products.
The disclosed figures stem from unaudited management accounts and may be adjusted after completion of the external audit and Audit Committee review. GAPACK plans to publish its audited FY2024 and FY2025 results on 8 April 2026.
Trading in the company’s shares has been suspended since 19 February 2025 and will remain halted until further notice. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.
Comments